General Information of the Compound
Compound ID
CP0345915
Compound Name
3-Methyl-4-oxo-2-phenyl-4H-chromene-8-carboxylic acid {3-[4-(2-methoxy-phenyl)-piperazin-1-yl]-propyl}-amide
    Show/Hide
Synonyms
SB-216469
152735-23-4
4H-1-Benzopyran-8-carboxamide,N-[3-[4-(2-methoxyphenyl)-1-piperazinyl]propyl]-3-methyl-4-oxo-2-phenyl-
AC1L3XX2
ACMC-20n6iu
AKOS030553705
BDBM50057465
CHEMBL278865
CTK4C7558
DTXSID70165115
GTPL496
L000508
N-[3-[4-(2-methoxyphenyl)piperazin-1-yl]propyl]-3-methyl-4-oxo-2-phenylchromene-8-carboxamide
REC-15-2739
REC-15-2869
REC-15-3011
REC-22/009
Rec 15-2739
Rec 15/2739
Rec-15-2739
SB 216469
SB 216469-S
SCHEMBL6638869
TXG28R7G4Y
UNII-TXG28R7G4Y
UPIDOSIN
Upidosin
Upidosin [INN]
ZINC3796141
    Show/Hide
Structure
Formula
C31H33N3O4
Molecular Weight
511.622
Canonical SMILES
COc1ccccc1N1CCN(CCCNC(=O)c2cccc3c2oc(c(C)c3=O)-c2ccccc2)CC1
    Show/Hide
InChI
InChI=1S/C31H33N3O4/c1-22-28(35)24-12-8-13-25(30(24)38-29(22)23-10-4-3-5-11-23)31(36)32-16-9-17-33-18-20-34(21-19-33)26-14-6-7-15-27(26)37-2/h3-8,10-15H,9,16-21H2,1-2H3,(H,32,36)
    Show/Hide
InChIKey
DUCNHKDCVVSJLG-UHFFFAOYSA-N
CAS
152735-23-4
Physicochemical Property
logP
4.71912
Rotatable Bonds
8
Heavy Atom Count
38
Polar Areas
75.02
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
6
Complexity
38

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 148842
SID: 14933744
ChEMBL ID
CHEMBL278865
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00819, 5-hydroxytryptamine receptor 1A
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000017 HeLa Homo sapiens (Human)  1
1
Ki = 5.9 nM
   TI
   LI
   LO
   TS
Protein ID: PT01089, Alpha-1A adrenergic receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000011 CHO Cricetulus griseus (Chinese hamster)  1
1
Ki = 0.34 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 Ki = 1 nM
Protein ID: PT01007, Alpha-1B adrenergic receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000011 CHO Cricetulus griseus (Chinese hamster)  1
1
Ki = 3.9 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 Ki = 31.62 nM
Protein ID: PT01004, Alpha-1D adrenergic receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000011 CHO Cricetulus griseus (Chinese hamster)  1
1
Ki = 1.5 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 Ki = 2.512 nM
Clinical Information about the Compound
Drug 1 ( REC-15-2739 )
Drug Name REC-15-2739
Company Recordati SpA
Indication
Prostate disease
Discontinued in Phase 2
Target(s)
Adrenergic receptor alpha-1A (ADRA1A)
Inhibitor
Adrenergic receptor alpha-1D (ADRA1D)
Modulator